.png){kind=icon}
.png){kind=icon}
Return
Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from 'castration-resistant' prostate cancer
.png){kind=icon}
OA
AI
DOI：10.1093/annonc/mdx312.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En
Keywords:
TRIALS WORKING GROUP
CLINICAL-TRIALS
RECOMMENDATIONS
ENZALUTAMIDE
ABIRATERONE
CHEMOTHERAPY
GUIDELINES
THERAPY
DESIGN
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
65.4
Papers:
3.4W
Citations:
6.4W
Organization
View more organizations